Ikbel Ghachem1, Samira Hadhri2, Hadef Skouri2
1Biology Laboratory, Taher Maamouri Hospital, Nabeul, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia.
This study found the JAK2V617F mutation in over 20% of splanchnic vein thrombosis (SVT) cases, indicating latent myeloproliferative neoplasms (MPNs). Screening for JAK2V617F is recommended in SVT patients with specific hematological markers.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: